PT  - JOURNAL ARTICLE
AU  - Yongkun Chen
AU  - Tian Bai
AU  - Sebastian Beck
AU  - Stephanie Stanelle-Bertram
AU  - Tao Chen
AU  - Jie Dong
AU  - Jing Yang
AU  - Lijie Wang
AU  - Dayan Wang
AU  - Yuelong Shu
AU  - Gülsah Gabriel
TI  - Low testosterone levels in H7N9 infected men correlate with high cytokine responses and lethal outcome: a retrospective cohort study
AID  - 10.1101/2020.05.07.20093914
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.07.20093914
4099  - http://medrxiv.org/content/early/2020/05/20/2020.05.07.20093914.short
4100  - http://medrxiv.org/content/early/2020/05/20/2020.05.07.20093914.full
AB  - Background Human infections with avian influenza A (H7N9) virus emerged in East China in March 2013. In contrast to seasonal influenza A viruses, H7N9 infections present a strong sex bias. Over the five epidemic waves in China, ~70% of all H7N9 cases were observed in men. We and others have independently shown that influenza A virus infections may significantly lower testosterone levels in male mice. In this study, we sought to analyze the role of testosterone in disease outcome in H7N9 infected men.Methods We systematically analyzed a total of n=330 human samples obtained from male and female subjects of two age groups (18-49 years and ≥50 years) with laboratory-confirmed H7N9 influenza, seasonal influenza (H1N1, H3N2) or negative control cohorts including H7N9 virus-negative close contacts and influenza virus-negative poultry workers in dependency of sex. The level of testosterone, estradiol as well as cytokines and chemokines were measured and compared in all study participants. We used regression analysis to evaluate the association of sex hormones and cytokines in dependency of sex and disease outcome.Results We analyzed sex hormones and innate immune responses in H7N9 cases (n=98), their H7N9 virus-negative close contacts (n=71), influenza virus-negative poultry workers (n=108) and mild seasonal (H1N1, H3N2) influenza cases (n=53). Samples were collected between 2014 and 2017. All control groups showed a similar median age within H7N9 cases except for the seasonal influenza group with a younger median age. In H7N9 infected men, testosterone levels were strongly reduced compared to male H7N9 virus-negative close contacts or males with seasonal influenza. Low testosterone levels in H7N9 infected men correlated with high inflammatory cytokine levels, e.g. IL-6, and lethal outcome in 18-49 year olds. No significant differences were detected in estradiol levels in H7N9 infected men. In H7N9 infected women (≥ 50 years), estradiol levels were elevated compared to H7N9 virus-negative close contacts without significantly affecting disease outcome.Conclusions Here, we show that low testosterone levels pose a poor prognostic marker in H7N9 infected men. Thus, treatment of H7N9 infected patients should consider sex-specific mitigation strategies.Key point Avian H7N9 infection presents a higher incidence in infected men compared to women. Low testosterone levels in H7N9 infected men correlate with high-level cytokine expression posing a high risk factor for lethal outcome.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the National Key Research and Development Program of China (2016YFC1200200 to Y.L.S. and 2016YFD0500208 to D.Y.W), the Guangdong Province Science and Technology Innovation Strategy Special Fund (2018A030310337 to Y.K.C), the German Free and Hanseatic City of Hamburg (to HPI (G.G.)) as well as the German Federal Ministry of Health (to HPI (G.G.)).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll generated data is available in this manuscript. No external repository was used.